|
1
|
Ad-hoc working group of ERBP. Fliser D,
Laville M, Covic A, Fouque D, Vanholder R, Juillard L and Van
Biesen W: A European renal best practice (ERBP) position statement
on the Kidney disease improving Global Outcomes (KDIGO) clinical
practice guidelines on acute kidney injury: Part 1: Definitions,
conservative management and contrast-induced nephropathy. Nephrol
Dial Transplant. 27:4263–4272. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Solomon RJ, Mehran R, Natarajan MK, Doucet
S, Katholi RE, Staniloae CS, Sharma SK, Labinaz M, Gelormini JL and
Barrett BJ: Contrast-induced nephropathy and long-term adverse
events: Cause and effect? Clin J Am Soc Nephrol. 4:1162–1169.
2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
James MT, Samuel SM, Manning MA, Tonelli
M, Ghali WA, Faris P, Knudtson ML, Rannu N and Hemmelgarn BR:
Contrast-induced acute kidney injury and risk of adverse clinical
outcomes after coronary angiography: A systematic review and
meta-analysis. Circ Cardiovasc Interv. 6:37–43. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Caixeta A, Nikolsky E and Mehran R:
Prevention and treatment of contrast-associated nephropathy in
interventional cardiology. Curr Cardiol Rep. 11:377–383.
2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Finn WF: The clinical and renal
consequences of contrast-induced nephropathy. Nephrol Dial
Transplant. 21:i2–i10. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Azzalini L, Spagnoli V and Ly HQ:
Contrast-induced nephropathy: From pathophysiology to preventive
strategies. Can J Cardiol. 32:247–255. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lau A, Chung H, Komada T, Platnich JM,
Sandall CF, Choudhury SR, Chun J, Naumenko V, Surewaard BG, Nelson
MC, et al: Renal immune surveillance and dipeptidase-1 contribute
to contrast-induced acute kidney injury. J Clin Invest.
128:2894–2913. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sun W, Yang Y, Xu C and Guo J: Regulatory
mechanisms of long noncoding RNAs on gene expression in cancers.
Cancer Genet. 216-217:105–110. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sallam T, Sandhu J and Tontonoz P: Long
noncoding RNA discovery in cardiovascular disease: Decoding form to
function. Circ Res. 122:155–166. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Paller MS, Hoidal JR and Ferris TF: Oxygen
free radicals in ischemic acute renal failure in the rat. J Clin
Invest. 74:1156–1164. 1984.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46.
2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lorenzen JM, Schauerte C, Kielstein JT,
Hubner A, Martino F, Fiedler J, Gupta SK, Faulhaber-Walter R,
Kumarswamy R, Hafer C, et al: Circulating long noncoding RNATapSaki
is a predictor of mortality in critically ill patients with acute
kidney injury. Clin Chem. 61:191–201. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chen Y, Qiu J, Chen B, Lin Y, Chen Y, Xie
G, Qiu J, Tong H and Jiang D: Long non-coding RNA NEAT1 plays an
important role in sepsis-induced acute kidney injury by targeting
miR-204 and modulating the NF-κB pathway. Int Immunopharmacol.
59:252–260. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yu TM, Palanisamy K, Sun KT, Day YJ, Shu
KH, Wang IK, Shyu WC, Chen P, Chen YL and Li CY: RANTES mediates
kidney ischemia reperfusion injury through a possible role of
HIF-1α and LncRNA PRINS. Sci Rep. 6(18424)2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cheng W, Li XW, Xiao YQ and Duan SB:
Non-coding RNA-Associated ceRNA networks in a new contrast-induced
acute kidney injury rat model. Mol Ther Nucleic Acids. 17:102–112.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Moore RD, Steinberg EP, Powe NR, Brinker
JA, Fishman EK, Graziano S and Gopalan R: Nephrotoxicity of
high-osmolality versus low-osmolality contrast media: Randomized
clinical trial. Radiology. 182:649–655. 1992.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dong M, Jiao Z, Liu T, Guo F and Li G:
Effect of administration route on the renal safety of contrast
agents: A meta-analysis of randomized controlled trials. J Nephrol.
25:290–301. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Karlsberg RP, Dohad SY and Sheng R:
Iodixanol Peripheral Computed Tomographic Angiography Study
Investigator Panel. Contrast medium-induced acute kidney injury:
Comparison of intravenous and intraarterial administration of
iodinated contrast medium. J Vasc Interv Radiol. 22:1159–1165.
2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu TQ, Luo WL, Tan X, Fang Y, Chen J,
Zhang H, Yu XF, Cai JR and Ding XQ: A novel contrast-induced acute
kidney injury model based on the 5/6-nephrectomy rat and
nephrotoxicological evaluation of iohexol and iodixanol in vivo.
Oxid Med Cell Longev. 2014(427560)2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sun S, Zhang T, Nie P, Hu L, Yu Y, Cui M,
Cai Z, Shen L and He B: A novel rat model of contrast-induced acute
kidney injury. Int J Cardiol. 172:e48–e50. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yang D, Yang D, Jia R and Tan J: Na+/Ca2+
exchange inhibitor, KB-R7943, attenuates contrast-induced acute
kidney injury. J Nephrol. 26:877–885. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang Z, Bao W, Zou X, Tan P, Chen H, Lai
C, Liu D, Luo Z and Huang M: Co-expression analysis reveals
dysregulated miRNAs and miRNA-mRNA interactions in the development
of contrast-induced acute kidney injury. PLoS One.
14(e0218574)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Society of Toxicolgoy. Guiding principles
in the use of animals in toxicology. Adopted by the Society of
Toxicology in July 1989. Toxicol Appl Pharmacol.
178(4p)2002.PubMed/NCBI
|
|
28
|
Kim D, Langmead B and Salzberg SL: HISAT:
A fast spliced aligner with low memory requirements. Nat Methods.
12:357–360. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pertea M, Kim D, Pertea GM, Leek JT and
Salzberg SL: Transcript-level expression analysis of RNA-seq
experiments with HISAT, StringTie and Ballgown. Nat Protoc.
11:1650–1667. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tafer H and Hofacker IL: RNAplex: A fast
tool for RNA-RNA interaction search. Bioinformatics. 24:2657–2663.
2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The urihttp://microRNA.orgsimplemicroRNA.org resource:
Targets and expression. Nucleic Acids Res. 36 (Database
Issue):D149–D153. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Aoki-Kinoshita KF and Kanehisa M: Gene
annotation and pathway mapping in KEGG. Methods Mol Biol.
396:71–91. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Pertea M, Pertea GM, Antonescu CM, Chang
TC, Mendell JT and Salzberg SL: StringTie enables improved
reconstruction of a transcriptome from RNA-seq reads. Nat
Biotechnol. 33:290–295. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sun L, Zhang Z, Bailey TL, Perkins AC,
Tallack MR, Xu Z and Liu H: Prediction of novel long non-coding
RNAs based on RNA-Seq data of mouse Klf1 knockout study. BMC
Bioinformatics. 13(331)2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kong L, Zhang Y, Ye ZQ, Liu XQ, Zhao SQ,
Wei L and Gao G: CPC: Assess the protein-coding potential of
transcripts using sequence features and support vector machine.
Nucleic Acids Res. 35:W345–W349. 2007.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Sun L, Luo H, Bu D, Zhao G, Yu K, Zhang C,
Liu Y, Chen R and Zhao Y: Utilizing sequence intrinsic composition
to classify protein-coding and long non-coding transcripts. Nucleic
Acids Res. 41(e166)2013.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Tang C, Ma Z, Zhu J, Liu Z, Liu Y, Liu Y,
Cai J and Dong Z: P53 in kidney injury and repair: Mechanism and
therapeutic potentials. Pharmacol Ther. 195:5–12. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Heyman SN, Rosen S, Khamaisi M, Idee JM
and Rosenberger C: Reactive oxygen species and the pathogenesis of
radiocontrast-induced nephropathy. Invest Radiol. 45:188–195.
2010.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Liss P, Nygren A, Erikson U and Ulfendahl
HR: Injection of low and iso-osmolar contrast medium decreases
oxygen tension in the renal medulla. Kidney Int. 53:698–702.
1998.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Rosenberger C, Rosen S and Heyman SN:
Renal parenchymal oxygenation and hypoxia adaptation in acute
kidney injury. Clin Exp Pharmacol Physiol. 33:980–988.
2006.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Yan M, Tang C, Ma Z, Huang S and Dong Z:
DNA damage response in nephrotoxic and ischemic kidney injury.
Toxicol Appl Pharmacol. 313:104–108. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lin J, Zhang X, Xue C, Zhang H, Shashaty
MG, Gosai SJ, Meyer N, Grazioli A, Hinkle C, Caughey J, et al: The
long noncoding RNA landscape in hypoxic and inflammatory renal
epithelial injury. Am J Physiol Renal Physiol. 309:F901–F913.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chang J, Ma JZ, Zeng Q, Cechova S, Gantz
A, Nievergelt C, O'Connor D, Lipkowitz M and Le TH: Loss of GSTM1,
a NRF2 target, is associated with accelerated progression of
hypertensive kidney disease in the African American Study of Kidney
Disease (AASK). Am J Physiol Renal Physiol. 304:F348–F355.
2013.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Gigliotti JC, Tin A, Pourafshar S, Cechova
S, Wang YT, Sung SJ, Bodonyi-Kovacs G, Cross JV, Yang G, Nguyen N,
et al: GSTM1 deletion exaggerates kidney injury in experimental
mouse models and confers the protective effect of cruciferous
vegetables in mice and humans. J Am Soc Nephrol. 31:102–116.
2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Janssen B, Hohenadel D, Brinkkoetter P,
Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, de Heer
E, et al: Carnosine as a protective factor in diabetic nephropathy:
Association with a leucine repeat of the carnosinase gene CNDP1.
Diabetes. 54:2320–2327. 2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Kilis-Pstrusinska K: Carnosine and kidney
diseases: What we currently know? Curr Med Chem. 27:1764–1781.
2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Machado RA, Constantino Lde S, Tomasi CD,
Rojas HA, Vuolo FS, Vitto MF, Cesconetto PA, de Souza CT, Ritter C
and Dal-Pizzol F: Sodium butyrate decreases the activation of NF-κB
reducing inflammation and oxidative damage in the kidney of rats
subjected to contrast-induced nephropathy. Nephrol Dial Transplant.
27:3136–3140. 2012.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Toso A, Leoncini M, Maioli M, Tropeano F,
Di Vincenzo E, Villani S and Bellandi F: Relationship between
inflammation and benefits of early high-dose rosuvastatin on
contrast-induced nephropathy in patients with acute coronary
syndrome: The pathophysiological link in the PRATO-ACS study
(Protective Effect of Rosuvastatin and Antiplatelet Therapy on
Contrast-Induced Nephropathy and Myocardial Damage in Patients With
Acute Coronary Syndrome Undergoing Coronary Intervention). JACC
Cardiovasc Interv. 7:1421–1429. 2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Chen YH, Fu YC and Wu MJ: Does resveratrol
play a role in decreasing the inflammation associated with contrast
induced nephropathy in rat model? J Clin Med. 8(147)2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Shen J, Wang L, Jiang N, Mou S, Zhang M,
Gu L, Shao X, Wang Q, Qi C, Li S, et al: NLRP3 inflammasome
mediates contrast media-induced acute kidney injury by regulating
cell apoptosis. Sci Rep. 6(34682)2016.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Andreucci M, Lucisano G, Faga T, Bertucci
B, Tamburrini O, Pisani A, Sabbatini M, Salzano S, Vitale M, Fuiano
G, et al: Differential activation of signaling pathways involved in
cell death, survival and inflammation by radiocontrast media in
human renal proximal tubular cells. Toxicol Sci. 119:408–416.
2011.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Ripoll VM, Irvine KM, Ravasi T, Sweet MJ
and Hume DA: Gpnmb is induced in macrophages by IFN-gamma and
lipopolysaccharide and acts as a feedback regulator of
proinflammatory responses. J Immunol. 178:6557–6566.
2007.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zhou L, Zhuo H, Ouyang H, Liu Y, Yuan F,
Sun L, Liu F and Liu H: Glycoprotein non-metastatic melanoma
protein b (Gpnmb) is highly expressed in macrophages of acute
injured kidney and promotes M2 macrophages polarization. Cell
Immunol. 316:53–60. 2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Malik S, Suchal K, Bhatia J, Gamad N,
Dinda AK, Gupta YK and Arya DS: Molecular mechanisms underlying
attenuation of cisplatin-induced acute kidney injury by epicatechin
gallate. Lab Invest. 96:853–861. 2016.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Matsuda A, Suzuki Y, Honda G, Muramatsu S,
Matsuzaki O, Nagano Y, Doi T, Shimotohno K, Harada T, Nishida E, et
al: Large-scale identification and characterization of human genes
that activate NF-kappaB and MAPK signaling pathways. Oncogene.
22:3307–3318. 2003.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Basile DP, Bonventre JV, Mehta R, Nangaku
M, Unwin R, Rosner MH, Kellum JA and Ronco C: ADQI XIII Work Group.
Progression after AKI: Understanding maladaptive repair processes
to predict and identify therapeutic treatments. J Am Soc Nephrol.
27:687–697. 2016.PubMed/NCBI View Article : Google Scholar
|
